Researchers studied the outcomes of intraoperative transfusion for patients undergoing operations between Jan. 1, 2005, to Dec. 31, 2009. They found patients who received intraoperative infusion of one unit of packed red blood cells had a higher risk of mortality, wound problems, pulmonary complications, postoperative renal dysfunction, systemic sepsis, composite morbidity and postoperative length of stay compared with patients who did not receive intraoperative transfusion.
The authors recommended caution when intraoperative transfusions are used for mildly hypovolemic or anemic patients.
Related Articles on Surgical Outcomes:
Measuring Surgical Outcomes: Are Surgical Objectives Important Enough to Document?
Changes in Ocular Alignment After General Anesthesia May Indicate Surgical Outcomes
Management of Asymptomatic Left Ventricular Dysfunction Improves Post-Surgical Outcomes in Vascular Patients
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
